News from the healthcare data industry
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
Program open at no-cost to any academic researcher interested in submitting a proposal March 10, 2022 08:00 AM Eastern Standard Time OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) and the University of Oxford...
MIAMI—Google Health is expanding the capabilities of its clinician-facing search tool using artificial intelligence to bring context to physicians’ clinical notes. Speaking at the ViVE 2022 conference, Paul Muret, vice president and...
March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence...
Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine The words artificial intelligence (AI) and ‘machine learning’ (ML) are likely familiar to...
by Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI 01/24/2022 Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the...
26th January 2022 Sensyne Health plc, the UK clinical AI company, says it has successfully completed the financing announced on 14 January 2022. This follows warnings from the board that...
January 24, 2022 By Sebastian Moss IBM will sell its Watson Health business to global investment firm Francisco Partners. The transaction is expected to close in the second quarter of 2022...
January 18, 2022 | Trends from the Trenches—Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as...